Health Care & Life Sciences » Pharmaceuticals | Jiangsu Kanion Pharmaceutical Co. Ltd.

Jiangsu Kanion Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
300,682.90
323,110.50
365,243.40
376,145.90
378,181.50
437,602.10
Depreciation, Depletion & Amortization
63,481.20
89,653.70
108,314.00
141,427.80
153,975.40
160,737.60
Other Funds
52,579.10
295,711.00
35,220.80
83,845.10
11,106.90
52,385.20
Funds from Operations
396,806.90
451,837.70
497,520.20
540,748.30
585,110.80
650,692.80
Changes in Working Capital
7,976.70
140,294.10
17,556.40
241,317.20
201,696.60
3,219.10
Net Operating Cash Flow
388,830.10
311,543.60
515,076.60
299,431.10
383,414.20
647,473.70
Capital Expenditures
339,224.70
309,363.50
374,795.50
325,240.30
260,940.70
Sale of Fixed Assets & Businesses
8,926.30
1,946.70
5,020.30
11,585.20
11,090.30
Purchase/Sale of Investments
4,104.40
360.00
9,300.00
11,354.10
127,066.00
Net Investing Cash Flow
310,521.30
307,776.80
351,879.40
318,813.50
384,456.80
Cash Dividends Paid - Total
29,095.30
49,877.60
51,370.80
143,838.10
36,986.90
Issuance/Reduction of Debt, Net
50,350.00
15,580.40
408,516.30
106,036.00
96,086.40
Net Financing Cash Flow
132,024.40
261,413.70
495,107.90
46,043.00
47,992.60
Net Change in Cash
53,796.20
265,187.60
331,825.90
26,675.50
46,950.00
Free Cash Flow
49,605.50
2,180.10
140,281.10
25,809.20
122,473.60
Deferred Taxes & Investment Tax Credit
2,900.40
917.70
2,556.50
907.80
413.00
32.10
Net Assets from Acquisitions
-
-
-
-
7,540.40
Other Sources
15,672.60
-
29,185.50
6,195.70
-
Exchange Rate Effect
80.60
7.10
84.70
15.00
-
Other Uses
-
-
1,989.70
-
-

About Jiangsu Kanion Pharmaceutical Co.

View Profile
Address
Jiangning Industrial City
Lianyungang Jiangsu 222047
China
Employees -
Website http://www.kanion.com
Updated 07/08/2019
Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicine pretreatment and extraction. It focuses on respiratory, gynecological, cardiovascular, and orthopedic disease. The company was founded on December 2, 2000 and is headquartered in Lianyungang, China.